EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dynamic Combinatorial Chemistry Unveils Nsp10 Inhibitors with Antiviral Potential Against SARS‐CoV‐2

Ravindra P Jumde iD, Gwenaëlle Jézéquel iD, Margarida Saramago iD, Nicolas Frank, Sebastian Adam iD, Marta V Cunha iD, Chantal D Bader iD, Antonia P Gunesch iD, Natalie M Köhler iD, Sandra Johannsen iD, Spyridon Bousis, Thomas Pietschmann iD und 4 weitere

Chemistry – A European Journal · 2025

DOI: 10.1002/chem.202403390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Ravindra P Jumde und 15 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123, Saarbrücken, Ge…. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Viral Nonstructural Proteins, Exoribonucleases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FCT - Fundação para a Ciência e a Tecnologia, I.P., through MOSTMICRO-ITQB R&D Unit, LS4FUTURE Associated Laboratory, FCT - Fundação para a Ciência e a Tecnologia, I.P..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of antiviral drugs against the Severe Acute Respiratory Syndrome coronavirus 2 (SARS‐CoV‐2) responsible for the recent Covid‐19 pandemic is crucial, as treatment options remain limited and vaccination does not prevent (re)infection. Two relatively underexplored targets of this virus are the 3′‐5′ exoribonuclease (ExoN) and the 2’‐ O ‐methyltransferase (2′‐ O ‐MTase), both essential for viral viability. The non‐structural proteins Nsp14 and Nsp16 exhibit enzymatic activities for ExoN and 2′‐ O ‐MTase, respectively, especially when in complex with their co‐factor protein Nsp10. The study focuses on the use of target‐directed dynamic combinatorial chemistry (tdDCC) to identify binders of Nsp10, aiming to disturb the protein‐protein interactions (PPI) involving Nsp10‐Nsp14, as well as Nsp10‐Nsp16. We synthesised the hits and evaluated them to assess Nsp10 affinity, ExoN and 2′‐ O ‐MTase activities inhibition, and antiviral activity in hCoV‐229E and SARS‐CoV‐2‐infected whole‐cell settings. This study reports a novel class of ExoN and/or 2′‐ O ‐MTase inhibitors exhibiting antiviral activity against coronaviruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSARS-CoV-2Viral Nonstructural ProteinsExoribonucleasesCOVID-19 Drug TreatmentEnzyme InhibitorsHumansCombinatorial Chemistry TechniquesMethyltransferasesCOVID-19Protein BindingViral Regulatory and Accessory Proteins

Stichwörter der Autor:innen

Nsp10Nsp14Nsp16SARS-CoV-2target-directed dynamic combinatorial chemistry

Substanzen

Antiviral AgentsViral Nonstructural ProteinsExoribonucleasesMethyltransferasesEnzyme InhibitorsViral Regulatory and Accessory ProteinsNSP16 protein, SARS-CoV-2NSP14 protein, SARS-CoV-2ORF1ab polyprotein, SARS-CoV-2

Autor:innen und Institutionen

  • Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123, Saarbrücken, Germany.
  • Current address, Global Antibiotic Research & Development Partnership (GARDP), Chemin Camille-Vidart 15, 1202, Geneva, Switzerland.
  • Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, 2780-157, Oeiras, Portugal.
  • Saarland University, Department of Pharmacy, Campus E 8.1, 66123, Saarbrücken, Germany.
  • Institute for Experimental Virology, Twincore - Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7, 30625, Hannover, Germany.
  • Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, 30625, Hannover, Germany.

ORCID-Profile: Ravindra P Jumde, Gwenaëlle Jézéquel, Margarida Saramago, Sebastian Adam, Marta V Cunha, Chantal D Bader, Antonia P Gunesch, Natalie M Köhler, Sandra Johannsen, Thomas Pietschmann, Rute G Matos, Rolf Müller, Cecília M Arraiano, Anna K H Hirsch

Förderung

  • FCT - Fundação para a Ciência e a Tecnologia, I.P., through MOSTMICRO-ITQB R&D Unit
  • LS4FUTURE Associated Laboratory
  • FCT - Fundação para a Ciência e a Tecnologia, I.P.
  • FCT - Fundação para a Ciência e a Tecnologia, I.P. contract according to DL57/2016
  • Niedersächsisches Ministerium für Wissenschaft und Kultur (Ministry for Science and Culture of Lower Saxony)
  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy - EXC 2155 "RESIST"

Zitieren

APA

Jumde, R. P., Jézéquel, G., Saramago, M., Frank, N., Adam, S., Cunha, M. V., Bader, C. D., Gunesch, A. P., Köhler, N. M., Johannsen, S., Bousis, S., Pietschmann, T., Matos, R. G., Müller, R., Arraiano, C. M., & Hirsch, A. K. H. (2025). Dynamic Combinatorial Chemistry Unveils Nsp10 Inhibitors with Antiviral Potential Against SARS‐CoV‐2. Chemistry – A European Journal. https://doi.org/10.1002/chem.202403390

Vancouver

Jumde RP, Jézéquel G, Saramago M, Frank N, Adam S, Cunha MV, et al. Dynamic Combinatorial Chemistry Unveils Nsp10 Inhibitors with Antiviral Potential Against SARS‐CoV‐2. Chemistry – A European Journal. 2025. doi:10.1002/chem.202403390

BibTeX
@article{Jumde2025,
  author = {Jumde, Ravindra P and Jézéquel, Gwenaëlle and Saramago, Margarida and Frank, Nicolas and Adam, Sebastian and Cunha, Marta V and Bader, Chantal D and Gunesch, Antonia P and Köhler, Natalie M and Johannsen, Sandra and Bousis, Spyridon and Pietschmann, Thomas and Matos, Rute G and Müller, Rolf and Arraiano, Cecília M and Hirsch, Anna K H},
  title = {Dynamic Combinatorial Chemistry Unveils Nsp10 Inhibitors with Antiviral Potential Against SARS‐CoV‐2},
  journal = {Chemistry – A European Journal},
  year = {2025},
  doi = {10.1002/chem.202403390}
}
Kostenlos starten →